AzTrials
AzTrials

Tooth LossNCT02174198

Bone Remodeling After Immediate Implant Placement With and Without Bone Grafting

A study testing BioOss Collagen at the time of implant placement in people with Tooth Loss, run by Columbia University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study compares two ways of placing a dental implant on the day of tooth extraction. One method will place a additional bone graft (derived from bovine bone) and the other group will not have the graft placed. Both groups will be restored at the same time with an immediate crown. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Tooth Loss
What is being tested?
BioOss Collagen at the time of implant placement
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteUnited States
Study dates
Jan 2014to Aug 2018
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Subject must have read, understood and signed an informed consent form.
  • Subjects must be willing and able to follow study procedures and instructions.
  • Subjects must have labial plate of bone present after extraction no more than 4 mm from the free gingival margin.
  • Subjects must require one maxillary anterior implant.
  • Subjects must be older than 18 years

Who cannot join

  • Subjects having participated within the last six months in other clinical studies.
  • Subjects who have failed to maintain good plaque control.
  • Subjects with any systemic condition like uncontrolled diabetes mellitus, cancer, human immunodeficiency virus (HIV), disorders that compromise wound healing, chronic high dose steroid therapy, bone metabolic diseases, radiation or other immuno-suppressive therapy which would preclude periodontal surgery.
  • Subjects with the presence of acute infectious lesions in the areas intended for surgery.
  • History within the last 6 months of weekly or more frequent use of smokeless chewing tobacco, pipe or cigar smoking and cigarette smoking (greater than 10 cigarettes per day).
  • Female subjects who are pregnant or lactating, or who intend to become pregnant during the study period following entrance into the study.
Show all 11Show fewer
  • Subjects on Bisphosphonate Therapy with C-terminal telopeptide (CTX) values <100
  • Subjects requiring antibiotic prophylaxis for subacute bacterial endocarditis (SBE) or late prosthetic joint infection. Patients who cannot undergo standard oral surgery procedure for any reason.
  • Subjects that have adjacent teeth next to tooth slated for extraction and immediate placement showing periodontal disease, endodontic and/or caries pathology will be excluded.
  • Subjects having unfavorable occlusal schemes for immediate loading, parafunctional habits and inadequate posterior support to properly protect the anterior teeth during function.
  • Implant site will not be next to an adjacent implant.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Columbia University, College of Dental Medicine

    New York, New York, 10032

Other trials in United States

About this study

Official title: The Esthetic Effect of Bio-OSS Collagen® on the Mid-facial Gingival Dimensions When Placed Into Gaps Between 3i® Implants Placed Into Fresh Extraction Sockets and the Labial Plate of Bone

This study compares two ways of placing a dental implant on the day of tooth extraction. One method will place a additional bone graft (derived from bovine bone) and the other group will not have the graft placed. Both groups will be restored at the same time with an immediate crown.

The investigators will be researching and comparing the changes in gum level that occur after each surgical method, as well as changes in jaw width where the implant is placed.

The investigators will enroll 16 patients per group. The patients will be followed for 3, 6, and 12 months post-immediate implant placement to observe healing.

Read the detailed description

The purpose of the current study is to evaluate the soft tissue dimensional changes after extraction of teeth in the esthetic zone, when combined with the placement of implants into these fresh extraction sockets. In addition, the effect of placing a graft material, such as Bio-Oss Collagen® into the gap between implant and the labial plate of bone will be evaluated after an immediately loaded provisional restoration is placed. 32 subjects will have an immediate dental implant placed in the maxillary anterior region (#4-12) after extraction of a hopeless tooth. 16 subjects will be randomly selected to receive Bio-Oss Collagen® (Test group) and 16 subjects will have no graft (Control group) in the gap between the implant and the labial plate of bone. Hopeless maxillary anterior teeth will be extracted and implants will be placed in a flapless procedure. Implants will be immediately loaded with provisional restorations once determined that the implant is stable. Changes in vertical height and horizontal dimensional changes of the free gingival margins will be evaluated at 3, 6, and 12 months post-immediate implant placement.

Conditions
Tooth Loss
Being tested
BioOss Collagen at the time of implant placement
Keywords
Immediate implant, bone graft, immediate restoration
Medical subject headings
Tooth Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BioOss Collagen at the time of implant placementDevice

    Also called BioOss Collagen, Geistlich Pharma Inc.

    Experimental: placement of BioOss Collagen No intervention: no BioOss Collagen

Study groups in NCT02174198
Study groupRoleWhat they receive
BioOss CollagenExperimentalIntervention: BioOss Collagen at the time of implant placement
Receives: Device: BioOss Collagen at the time of implant placement
No Bone GraftNo interventionNo placement of BioOss at the time of implant placement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean Bucco-Lingual Change at 3mm

    The horizontal dimensional change from a digital superimposition at 3mm apical to the baseline free gingival margin position was measured.

    Measured: Baseline and 12 months

  2. Mean Bucco-Lingual Change at 4mm

    The horizontal dimensional change from a digital superimposition at 4mm apical to the baseline free gingival margin position was measured.

    Measured: Baseline and 12 months

Secondary outcomes (7)
  1. Change in Vertical Dimension of Buccal Soft Tissue (Distal Papilla)

    The mean change was calculated from a tooth-supported stent to the free gingival margin.

    Measured: Baseline and 12 months

  2. Change in Vertical Dimension of Buccal Soft Tissue (Mid-buccal)

    The mean change was calculated from a tooth-supported stent to the free gingival margin.

    Measured: Baseline and 12 months

  3. Change in Vertical Dimension of Buccal Soft Tissue (Mesial Papilla)

    The mean change was calculated from a tooth-supported stent to the free gingival margin.

    Measured: Baseline and 12 months

  4. Periodontal Probing Depth

    The periodontal probing depth will be measured in mm.

    Measured: 12 months

  5. Thickness of Keratinized Tissue at 3mm

    Tissue thickness was measured at 3mm from the free gingival margin (FGM) using a 15-endodontic file and a rubber stopper.

    Measured: 12 months

  6. Thickness of Keratinized Tissue at 4mm

    Tissue thickness was measured at 4mm from the free gingival margin (FGM) using a 15-endodontic file and a rubber stopper.

    Measured: 12 months

  7. Thickness of Keratinized Tissue at 8mm

    Tissue thickness was measured at 8mm from the free gingival margin (FGM) using a 15-endodontic file and a rubber stopper.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jun 2014 (estimated)
  2. Study startJan 2014
  3. Primary completionAug 2018
  4. Study completionAug 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02174198
Sponsor's protocol ID
AAAM4053
Status last verified
May 2019
First submitted
23 Jun 2014
Last updated
13 Jun 2019
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing BioOss Collagen at the time of implant placement in people with Tooth Loss, run by Columbia University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Jun 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 13 Jun 2019). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean Bucco-Lingual Change at 3mm (time frame: Baseline and 12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jun 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in